相关实验视频
Updated: Jul 20, 2025

06:21
Assessment of the Metabolic Profile of Primary Leukemia Cells
Published on: November 21, 2018
10.5K
B细胞急性淋巴细胞白血病的生物化学和血液学概况 儿童 儿童
Ammara Khalid1, Mehboob Ahmed, Shahida Hasnain
1Institute of Microbiology and Molecular Genetics, University of the Punjab, Quaid e Azam Campus, Lahore, Pakistan.
Journal of pediatric hematology/oncology
|August 1, 2023
概括
这项研究分析了儿科B细胞急性淋巴细胞白血病 (B-ALL) 的血液学和生物化学概况. 关键发现揭示了B-ALL患者的血液样本变化和基于性别和年龄的显著生化差异.
科学领域:
- 儿科瘤学 儿科瘤学
- 血液学 血液学 血液学
- 临床生物化学 临床生物化学
背景情况:
- B细胞急性淋巴细胞白血病 (B-ALL) 是最常见的儿童白血病.
- 儿童白血病的预后因素包括诊断时间,白细胞计数,年龄和性别.
- 血液学和生化学概况对于在化疗前后评估患者健康至关重要.
研究的目的:
- 在儿科B-ALL病例中评估血液学和生物化学参数.
- 将这些参数与正常参考值进行比较.
- 确定与预后因素 (如年龄和性别) 的潜在相关性.
主要方法:
- 对200例儿科B-ALL病例的分析.
- 评估全血细胞计数 (CBC) 和白血差异计数.
- 评估功能测试,肝功能测试,血清电解质和血清蛋白质.
主要成果:
- 大多数病例是5岁以下的男性.
- 血液学揭示了较低的红细胞,血红蛋白和血小板,与正常人相比,白细胞的数量更高.
- 生物化学概况显示出基于性别和年龄的显著差异,而血液学概况没有显著变化.
结论:
- 儿科B-ALL患者表现出明显的血液学和生化学特征.
- 生物化学参数显示出受性别和年龄影响的显著变化.
- 这些发现强调了全面分析对B-ALL管理的重要性.
相关概念视频
Disorders of Leukocytes
982
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
982
Bone Marrow Sampling and Transplants
360
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
360

